LUMATE-AT Tabs.
MRP: 1,713
Packaging: 10x1x6
Pack Type: tablet
Composition:
Artemether 80mg + Lumefantrine 480mg
Indication:
Provides quick control on the symptoms of Malaria
Description:
Artemether 80mg + Lumefantrine 480mg Tablets**
This fixed-dose combination of Artemether (80mg) and Lumefantrine (480mg) is a potent antimalarial medication used in the treatment of acute uncomplicated Plasmodium falciparum malaria, including infections resistant to other antimalarials. Artemether, a fast-acting artemisinin derivative, rapidly kills malaria parasites in the blood, while Lumefantrine, a longer-acting agent, eliminates residual parasites and helps prevent recurrence.
This combination is a WHO-recommended artemisinin-based combination therapy (ACT) for malaria, ensuring high efficacy and reduced resistance development.
Tags:
- Effective treatment of drug-resistant malaria
- Rapid onset of action with Artemether
- Sustained parasite clearance by Lumefantrine
- Reduces chances of relapse and resistance
- Endorsed by WHO as frontline therapy
- Convenient fixed-dose oral formulation
Usage Information
Dosage
Adults & children over 35kg: Standard dose is 4 tablets (80mg/480mg) initially, then at 8, 24, 36, 48, and 60 hours (6 total doses). Must be taken with meals, ideally fatty food (e.g. milk, oil-based food). Do not skip doses. Ensure full 3-day course completion. Note: Dosage may vary based on body weight and region-specific guidelines.
Side Effects
Headache Dizziness Nausea, vomiting Abdominal pain Palpitations Insomnia Rare: Allergic reactions, QT prolongation (heart rhythm changes)
Contraindications
Hypersensitivity to artemether, lumefantrine, or related compounds Patients with severe malaria requiring parenteral therapy Individuals with QT prolongation or on QT-prolonging drugs Avoid in first trimester of pregnancy unless advised by a physician Do not use for malaria prevention or non-falciparum infections